VK2735 — ≥99% Research Peptide
Viking Therapeutics' Dual GLP-1 / GIP Receptor Agonist
Investigational dual incretin receptor agonist under development in both subcutaneous and oral formulations, with rapid weight-loss kinetics reported in early-phase trials.
Research Applications & Benefits
- Dual GLP-1 + GIP receptor activation
- Subcutaneous and oral formulations under development
- Rapid early-phase weight-loss kinetics
- Comparator to tirzepatide in research models
Product Specifications
- Compound
- VK2735
- CAS Number
- 2702966-26-5
- Molecular Weight
- ~4500 g/mol
- HPLC Purity
- ≥99% (independently verified by CertikLabs)
- Category
- GLP-1 & Metabolic
- Starting Price
- $169.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Every VK2735 batch sold by PeptidesDirect is independently tested for purity (HPLC), identity (LC-MS), and concentration. A batch-specific Certificate of Analysis is available on request and anchored to a CertikLabs verification record for public inspection.
Frequently Asked Questions
Is VK2735 suitable for human consumption?
No. VK2735 is sold strictly for in-vitro laboratory research. It is not a drug, supplement, cosmetic, or food product and must not be administered to humans or animals.
What purity is VK2735?
VK2735 ships at ≥99% verified by reverse-phase HPLC with mass-spec identity confirmation on every batch.
How is VK2735 shipped and stored?
Vials are shipped lyophilized in temperature-controlled packaging. Store unopened lyophilized peptide at −20°C; once reconstituted with bacteriostatic water, store at 2–8°C and use within 28 days.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
